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bstract
Neopterin is synthesized by human monocyte-derived macrophages upon stimulation with interferon- (IFN-). Measurement of neopterin
oncentration is useful to monitor cell-mediated (Th1-type) immune activation.
In this study, we aimed to analyze the behaviour of neopterin in long lasting asthma considering its role as a marker of the Th1 environment
nd to establish the distinction between patients belonging either to the allergic or the non-allergic population, particularly in the elderly where
sthma is often under diagnosed. Therefore we evaluated allergic parameters such as skin prick tests, IgE and hemogram (eosinophils count),
nd we compared our findings with neopterin values found in an age-matched control population.
A group of individuals older than 65 was selected. It included 64 asthmatic patients (mean age 72 ± 5 years) and 41 healthy individuals
mean age 79 ± 7 years). In our study population, 42 patients presented positive skin tests, mainly to house dust mites. All patients were
linically stable and presented an average percentage of predicted forced expiratory volume in the first second (FEV1) of 73.6 ± 25.3 and
redicted median expiratory flow percentage (MEF50) of 38.8 ± 26.7.
Blood cell counts showed statistically different mean values of eosinophils between allergic and non-allergic controls (5.42 ± 4.7% ver-
us 2.8 ± 2.8%; p < 0.04). IgE values were increased in allergic asthmatic patients when compared with non-allergic asthmatic patients
493.2 ± 549.8 IU/ml versus 85.3 ± 194.4 IU/ml; p = 0.000).
Allergic asthmatic patients presented mean neopterin levels similar to those found in the control group (2.4 ± 2.8 ng/ml versus
.1 ± 1.9 ng/ml). In contrast, in non-allergic asthmatic patients these values were higher when compared with the control group (4.0 ± 4.7 ng/ml
ersus 2.1 ± 1.9 ng/ml). Neopterin levels were lower in allergic asthmatic patients when compared with non-allergic asthmatic patients
2.4 ± 2.8 ng/ml versus 4.0 ± 4.7 ng/ml).
Within asthmatic patients, those with higher neopterin values (>2.1 ng/ml) presented lower mean IgE values (IgE ≤ 336.58 IU) than those
ith lower neopterin values (≤2.1 ng/ml) who presented mean IgE values of 402.70 IU.
Our initial findings may lead to a better understanding of the immunoinflammatory pathways in asthma. Further studies will probably show
hat serum neopterin could became a useful marker for asthma classification including in elderly patients with long lasting disease.
2006 Elsevier Ireland Ltd. All rights reserved.eywords: Neopterin; Asthma; Aging; IgE; Allergy. Introduction
Neopterin is synthesized by human monocyte-derived
acrophages upon stimulation with interferon- during the
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oi:10.1016/j.pathophys.2006.10.001h1-type immune response [1–3]. Measurement of neopterin
oncentration is useful to monitor cell-mediated (Th1-type)
mmune activation.
Asthma is a chronic inflammatory disorder of the air-
ays [4], affecting all ages [5] with a progressive decline of
ulmonary function that is correlated with age, sex disease
uration and severity [6,7]. Asthma is often under diagnosed
n the elderly and is sometimes associated with allergic trig-
ers. In allergic asthma, environmental control measures can
mprove the disease prognosis [8].
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Cell-mediated immune response depends on activation of
h1 cells, which typically produce and release interferon-
nd interleukin-2, whereas the activation of Th2 cells is char-
cterized by the release of cytokines such as interleukin-4,
nterleukin-5, and interleukin-10. Th2 cytokines are involved
n humoral immune response and trigger immunoglobulin
roduction like IgE that is associated with allergic disorders.
here is a cross-regulatory interplay between Th1-type and
h2-type immune responses associated with an inverse rela-
ionship between IgE and neopterin concentrations [1].
The studies in chronic asthma, that includes long disease
volution, can give important information since the changes
bserved are a result of continuous exposure to several trig-
ers and are often irreversible.
Neopterin concentrations may also be increased in the
lderly, which is associated with the fact that healthy elders
evelop several immune changes including activation, dereg-
lation and impaired cell function [9,10].
The aim of this study is to analyze the level of neopterin
n long-lasting asthma considering its role as a marker of Th1
nvironment, as well as to evaluate allergic parameters such
s IgE and blood cell counts.
. Material and methods
.1. Population
A group of 105 elderly individuals non-currently or for-
er smokers, which included 64 asthmatics (72 ± 5 years/42
llergic), and 41 controls (79 ± 7 years) were selected
Table 1). In this study the group of allergic asthmatics
ncluded 27 females and 15 males, while the non-allergic
nes included 16 females and 6 males. Informed consent
as obtained from all participants. Patients were observed in
n outpatient lung disease department for intermittent chest
ightness, wheezing or shortness of breath and reversible air-
ays obstruction for more than 30 years, consistent with
he diagnosis of mild persistent asthma according to Global
nitiative for Asthma criteria (GINA). They were controlled
sing beclometasone dipropionate, 250–500g, daily and all
ther anti-asthmatic drugs were suspended at least 4 weeks
rior to this study. The control group was recruited from
lderly residences.
None of the individuals had chronic sputum or had had
ny respiratory infection in the month previous to the study
nclusion. No other clinically relevant diseases were reported.
The following were considered exclusion criteria, both
or patients and controls: cancer, autoimmunity, infection,
able 1
ontrol group vs. asmathics group, sex and age distribution
opulation n Male/female Mean age Range
ontrol 41 12/29 79.2 ± 7.0 65/94
smathics 64 21/43 72.4 ± 5.1 65/83
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iabetes, heart failure, renal failure, chronic hepatic and expo-
ure the environmental risk factors.
.2. Methods
All 105 subjects in this study were submitted to
kin prick tests to 20 common aeroallergens ALK-
BELLO (1 mm Prick Lancetter-tames Hollister Stier): Der-
atophagoides pteronyssinus, Dermatophagoides farinae,
epidoglyphus destructor, Tyrophagus putrescenciae, Cla-
osporium herbarum, Alternaria tenuis, Blatella germanica,
at, dog, Dactylis glomerata, Phleum pratense, Poa pratensis,
lantago lanceolata, Taraxacum officinale, Parietaria judaica,
rtemisia vulgaris, Chenopodium album, Platanus, Quercus
uber e Olea europaea. Histamine dihydrochloride was used
s a positive control (10 mg/ml) and saline solution used as
egative control. Allergy was defined by positive skin prick
est, with wheal and flare diameter 3 mm greater than the
egative control to at least one aeroallergen tested.
All patients underwent clinical evaluation to fulfil the clin-
cal exclusion criteria and performed a spirometric test using
he same equipment (Vitalograph Compact) at least 6 h after
he last dose of any bronchodilator. Predicted values were
easured according to Knudson et al. [11]. Their spirometric
erformances were assessed using a computerized program
ccording to ATS’94 criteria. The approval for analysis was
etermined using the ATS’94 criteria; accuracy was achieved
f, within the same evaluation, three curves were acceptable
nd reproducible.
Thirty to 50 ml of peripheral blood was withdrawn from
ll participants.
Total serum IgG, IgA and IgM were measured by neph-
lometry and total serum IgE was measured using a com-
ercial Kit (Coat-A-Count® Total IgE IRMA, DPC®, CA,
SA) based on an Immuno-radiometric assay (IRMA) of
olid phase. This kit uses monoclonal antibodies anti-IgE
125
-labelled in the liquid phase and polyclonal antibodies
nti-IgE attached to the wall of the polystyrene tube. There-
ore, the IgE present in the tested sample is retained between
hese two antibodies. These tubes were measured using a
amma counter (Gamma-C-12, DPC®, CA, USA) for 1 min.
otal IgE concentration in the sample is directly proportional
o the counts per minute. This concentration was determined
y comparison with provided calibrators. Sensitivity of this
it is 0.5 IU/ml.
Neopterin levels were measured using an enzymatic
mmunoassay (ImmuChemTM, ICN Pharmaceuticals Inc.,
A, USA) with sensitivity between 0 ng/ml and 100 ng/ml,
n serum samples. The absorbance was read at 450 nm in a
icroplate reader. The absorbance is inversely proportional
o the amount of neopterin in the sample. All samples were
ollected and stored protected from light and all assays were
erformed avoiding direct sunlight exposure [12].
All the individuals enrolled in this study were thoroughly
xamined, including a complete laboratory work-up, and
hecked for potential exclusion criteria.
thophysiology 14 (2007) 35–39 37
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Table 2
Eosinophil and IgE values in asthmatics allergic group and asthmatics non-
allergic group
Population Asthmatics allergic
group (mean values)
Asthmatics non-allergic
group (mean values)
Eosinophil counts
(%)
5.42 ± 4.7 2.8 ± 2.8*
Eosinophil total
(cells/mm3)
375.6 ± 408.2 187.3 ± 185.4*
IgE values (IU/ml) 493.2 ± 549.8 85.3 ± 194.4**
t-Parametric test—statistical significance asthmatics allergic group vs. asth-
matics non-allergic group (*p = 0.04; **p = 0.000).
Table 3
Neopterin values in control group, asthmatics allergic group and asthmatics
non-allergic group
Population Neopterin values
(ng/ml)
Control group (n = 41) 2.1 ± 1.9
A
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ing group (n = 19) presented even higher neopterin levels
when compared with the control group (4.7 ± 4.8 ng/ml ver-
sus 2.1 ± 1.9 ng/ml; p < 0.05) (Table 5).
Table 4
Percentage of allergic and non-allergic asthmatics presenting increased
neopterin values
Neopterin values (ng/ml) >2.1
Asthmatics allergic group (%) 34
Asthmatics non-allergic group (%) 58*
t-Parametric test—statistical significance asthmatics allergic group vs. asth-
matics non-allergic group (*p < 0.05).
Table 5
Neopterin values in control group, asthmatics allergic group and asthmatics
non-allergic group
Population Neopterin values
(ng/ml)
Control group (n = 41) 2.1 ± 1.9A. Mota Pinto et al. / Pa
.3. Statistical analysis
Statistical calculations were performed using SPSS 12.0
oftware package. Kolmogorov–Smirnov test was used to
heck if variables were normally distributed. For those who
ad a normal distribution it was used the parametric t-test
or two independent parameters. Variables that were not dis-
ributed normally were evaluated using Mann–Whitney non-
arametric test. Significance is defined as a p-value < 0.05.
ata are expressed as the mean ± standard deviation (S.D.).
. Results
All patients were clinically stable and presented an aver-
ge percentage of predict forced expiratory volume in the
rst second (FEV1) of 73.6 ± 25.3 and median expiratory
ow percentage of predict (MEF50) of 38.8 ± 26.7 and a
iffeneau index of 82.8 ± 13.1. The bronchial hyperreactivity
tudies done in all individuals with FEV1 lower than 85% of
he predicted, showed a median increase of 10.7 ± 5.4% in
EV1 after 200g of inhaled albuterol.
Among the asthmatic individuals, 42 subjects (65.6%)
ere considered allergic because they presented positive skin
rick tests to common aeroallergens. Allergic patients pre-
ented positive skin prick tests to common aeroallergens and
ost of them were polysensitized. The non-allergic group (22
atients) did not react to common aeroallergens, though in 3
ases drug hypersensitivity had previously been reported (2
o non-steroidal anti-inflammatory drugs and 1 to penicillin).
We found a significant difference in eosinophil counts
etween allergic and non-allergic patients (mean val-
es 5.42 ± 4.7% versus 2.8 ± 2.8% and total values
75.6 ± 108.2 cells/mm3 versus 187.3 ± 185.4 cells/mm3;
< 0.04).
IgG mean values were increased in allergic asthmatic
atients when compared with non-allergic asthmatic patients
11.9 ± 2.5 g/l versus 10.4 ± 2.2 g/l; p = 0.03).
IgA and IgM mean values of allergic asthmatic
atients were compared to non-allergic asthmatic patients
3.2 ± 1.4 g/l versus 2.6 ± 1.3 g/l; 1.1 ± 0.5 g/l versus
.2 ± 0.7 g/l, respectively) and there were no significant
ifferences.
IgE mean levels were significantly increased in
llergic asthmatic patients when compared with non-
llergic asthmatic patients (493.2 ± 549.8 IU/ml versus
5.3 ± 194.4 IU/ml; p = 0.000) (Table 2).
Neopterin was decreased in allergic asthmatic patients
hen compared with non-allergic asthmatic patients
2.4 ± 2.8 ng/ml versus 4.0 ± 4.7 ng/ml).
Allergic asthmatic patients presented mean neopterin lev-
ls similar to those found in the control group (2.4 ± 2.8 ng/ml
ersus 2.1 ± 1.9 ng/ml). In contrast, in non-allergic asthmatic
atients these values were increased when compared with
he control group (4.0 ± 4.7 ng/ml versus 2.1 ± 1.9 ng/ml)
Table 3).
A
A
t
asthmatics allergic group (n = 42) 2.4 ± 2.8
sthmatics non-allergic group (n = 22) 4.0 ± 4.7
Fifty-eight percent of non-allergic patients presented
erum neopterin levels above normal (>2.1 ng/ml) while only
4% of allergic asthmatic had serum neopterin levels above
hat value (p < 0.05) (Table 4). Within asthmatic patients,
hose with increased neopterin values (>2.1 ng/ml) presented
ower mean IgE values (IgE ≤ 336.58 IU) than those with
ecreased neopterin values (≤2.1 ng/ml), which presented
ean IgE values of 402.70 IU.
Moreover, if the three non-allergic patients (without sen-
itivity to common aeroallergens) with drug hypersensiv-
ty were withdrawn from the study, because they could
resent a shift to Th2 cytokine environment, the remain-sthmatics allergic group (n = 42) 2.4 ± 2.8
sthmatics non-allergic group (without drug
hypersensitivity) (n = 19)
4.7 ± 4.8*
-Parametric test—statistical significance control group vs. asthmatics non-
llergic group (*p < 0.05).
3 thophys
4
a
g
a
t
a
c
i
t
t
(
a
r
o
t
p
a
b
t
i
i
s
c
d
s
t
c
o
fi
m
b
a
m
t
i
t
o
a
[
m
p
a
I
t
[
a
d
s
u
[
t
r
d
c
n
I
h
i
s
o
a
o
c
[
m
p
a
r
f
5
o
n
m
A
n
a
R8 A. Mota Pinto et al. / Pa
. Discussion
In this study, we investigated the serum levels of neopterin,
macrophage-derived biomarker, in individuals with aller-
ic and non-allergic asthma, and determined differences in
verage and overall range of its expression. Serum concen-
rations of neopterin and IgE were compared between both
sthmatic groups and controls in order to understand the
ross-regulatory interplay between Th1-type and Th2-type
mmune response.
One difficulty usually faced in asthma management is
he proper distinction between patients belonging either to
he allergic or the non-allergic population. Skin prick tests
SPT) can provide reliable information on this subject when
n appropriate group of allergen extracts is selected. Cur-
ently, some medical centres are directing their efforts at
btaining a European Standard Allergen Panel to improve
he accuracy of this diagnostic method [13]. There are also
atients with a strong evidence of allergy that present neg-
tive SPT to common allergens. Often, high IgE levels and
lood eosinophilia are observed in allergic disorders although
hese two parameters may also be elevated in other patholog-
cal conditions. In contrast, neopterin levels tend to decrease
n allergy and to increase in other pathological disorders
uch as pulmonary infections. Asthma, often starts during
hildhood but can affect all ages and cause an important
ecrease in lung function parameters [8]. The individuals
elected for this study, without exposure to specific inhala-
ory risks sources, were predominantly women. They were
arefully evaluated to exclude the presence of heart disease
r chronic obstructive pulmonary disease (COPD). The dif-
culties associated with the ageing process, such as chest
uscle weakness, arthritis or decline in vital capacity should
e considered in the evaluation of these patients. Although
sthma is defined as a reversible disease, long lasting asthma
ay lead to a persistent airflow obstruction and asymp-
omatic patients may maintain some functional pulmonary
mpairment due to chronic airway inflammation. According
o some authors, the narrowing of the airways and the level
f bronchial responsiveness are, in adults over 65, associ-
ted with atopy and allergy diagnosis should not be neglected
14]. Although IgE levels tend to decrease with age, an IgE-
ediated allergy can be present in 75% of elderly asthmatic
atients [15,16]. Proper assessment to accurately diagnose
llergic individuals will allow better therapeutic approaches.
n fact, in allergic patients, allergen avoidance is an impor-
ant goal to keep disease under control in any age group
17]. Higher neopterin levels were detected in non-allergic
sthmatic patients. This change is significant if patients with
rug hypersensitivity were excluded from the study group,
uggesting that in these cases, a Th2 pathway or a down reg-
lation of immunoinflammatory response could be present
18].
This finding reinforces the current theory that in humans
he activation of Th1 and Th2 cell-mediated immune
esponses down-regulate each other [19]. Th1 cells pro-iology 14 (2007) 35–39
uce IFN- and IL-2, thereby stimulating human mono-
ytes/macrophages to produce and release large amounts of
eopterin, which in turn could down-regulate the humoral
gE-mediated immune response.
In humans, increased serum concentrations of neopterin
ave also been found in autoimmune diseases and in viral
nfections. Furthermore, the respiratory infections are con-
idered main triggers in non-allergic asthma. Determination
f neopterin concentrations has turned out to be a sensitive
nd useful way of monitoring Th1-type immune response
nce significant association between enhanced blood con-
entrations of neopterin and IFN- have been observed
1].
These preliminary results could anticipate neopterin and
acrophages involvement in asthma, at least in the elderly
opulation with long lasting asthma. Accordingly, histamine,
n important mediator of Th2 cell-driven allergic reaction
eleased from mast cells, significantly suppresses neopterin
ormation [20].
. Conclusion
Our initial findings may lead to a better understanding
f the immunoinflammatory pathways in asthma. Serum
eopterin may prove a useful marker for classifying asth-
atic patients, including those in the elderly population.
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